All lobbying filings
SPLITOAK STRATEGIES LLC
Lobbying for CARIS SCIENCE INC · Providing precision medicine services to patients battling aggressive cancers.
Filing
1st Quarter - Report
Lobbying activity
2
Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act; HR 7148 the Consolidated Appropriations Act of 2026; updated timing of reporting under PAMA
Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools